ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Zivo Bioscience, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026
- Market cap
- $25.96M
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Sep 30, 2025
Total debt
$11.66K
Long-term debt
Net debt
-$45.56K
After $57.22K of cash
Implied interest rate
–
FY2024 interest ÷ average debt
Interest coverage
–
FY2024 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Zivo Bioscience's annual report. Trading prices and yields need FINRA TRACE data.